Skip to main content
Log in

In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of α2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The activation of α2-adrenergic heteroreceptors was studied by comparing the effectiveness of the electrical stimulation of the ascending 5-HT pathway in suppressing the firing activity of CA3 dorsal hippocampus pyramidal neurons prior to, and following, the intravenous administration of noradrenergic agents. Desipramine (2 mg/kg), a selective noradrenaline reuptake blocker, reduced the efficacy of the stimulation; this effect was reversed by the α2-adrenoceptor antagonists yohimbine (0.5 mg/kg) and (-)mianserin (0.5 mg/kg), but not by idazoxan (0.5 mg/kg), an adrenoceptor antagonist with preferential affinity for the imidazoline recognition sites. Low doses of the α2-adrenoceptor agonist clonidine (2 and 10 μg/kg) enhanced the efficacy of the stimulation, while high doses (100 and 400 μg/kg) reduced it. These incremental and decremental effects of clonidine were reversed by 0.1 and 1 mg/kg of yohimbine, respectively. The enhancing effect of the low dose of clonidine (10 μg/kg) was abolished in rats pretreated with the noradrenaline neurotoxin 6-hydroxydopamine. However, the inhibitory effect of a high dose of clonidine (100 μg/kg) was unaltered by this pretreatment. These results indicate that low doses of clonidine preferentially activate α2-adrenergic autoreceptors on the noradrenaline neurons resulting in a reduction of the tonic inhibitory effect of endogenous noradrenaline on 5-HT neurotransmission, while higher doses of clonidine would decrease 5-HT neurotransmission through the direct activation of α2-adrenergic heteroreceptors on 5-HT terminals. Furthermore, the selective α2-adrenergic heteroreceptors antagonist(-)mianserin (0.5 mg/kg) increased by itself the efficacy of 5-HT neurotransmission, an effect not observed with yohimbine and idazoxan. Taken together, these results suggest that, in vivo, the α2-adrenoceptors on 5-HT terminals of the rat hippocampus are tonically activated by endogenous noradrenaline and modulate 5-HT release.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Atlas D, Diamant S, Fales HR, Pannel L (1987) The brain's own clonidine: purification and characterization of endogenous clonidine displacing substance from brain. J Cardiol Pharmacol 10:S122-S127

    Google Scholar 

  • Benkirane S, Arbilla S, Langer S (1985) Supersensitivity of α2-adrenoceptors modulating [3H]5-HT release after noradrenergic denervation with DSP4. Eur J Pharmacol 119:131–133

    Google Scholar 

  • Blier P, de Montigny C, Tardif D (1984) Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: Single-cell studies in the rat. Psychopharmacology 84:242–249

    Google Scholar 

  • Chaput Y, de Montigny C, Blier P (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 333:342–348

    Google Scholar 

  • Curet O, de Montigny C (1989) Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. III. Evidence for the physiological role of terminal a2-adrenergic autoreceptors. Brain Res 499:18–26

    Google Scholar 

  • de Montigny C, Wang RY, Reader TA, Aghajanian GK (1980) Monoaminergic denervation of the rat hippocampus: Microiontophoretic studies on pre- and postsynaptic supersensitivity to noradrenaline and serotonin. Brain Res 200:363–376

    Google Scholar 

  • Ellison DW Campbell IC (1986) Studies on the role of α2-adrenoceptors in the control of synaptosomal [3H]5-hydroxytryptamine release: Effects of antidepressant drugs. J Neurochem 46:218–223

    Google Scholar 

  • Ernsberger P, Meeley MP, Reis DJ (1988) An endogenous substance with clonidine-like properties: Selective binding to imidazole sites in the ventrolateral medulla. Brain Res 441:309–318

    Google Scholar 

  • Feuerstein TJ, Hertting G, Jackisch R (1985) Endogenous noradrenaline as modulator of hippocampal serotonin (5-HT) release. Naunyn-Schmiedeberg's Arch Pharmacol 329:216–221

    Google Scholar 

  • Frankhuijzen A, Mulder AH (1982) Pharmacological characterization of presynaptic α-adrenoceptors modulating [3H]noradrenaline and [3H]5-hydroxytryptamine release from slices of the hippocampus of the rat. Eur J Pharmacol 81:97:106

    Google Scholar 

  • Frankhuijzen AL, Wardeh G, Hogenboom F, Mulder AH (1988) Alpha-2 adrenoceptor mediated inhibition of the release of radio-labelled 5-hydroxytryptamine and noradrenaline from slices of the dorsal region of the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 337:255–260

    Google Scholar 

  • Galzin AM, Moret C, Langer SZ (1984) Evidence that exogenous but not endogenous noradrenaline activates the presynaptic alpha-2 adrenoceptors on serotonergic nerve endings in the rat hypothalamus. J Pharmacol Exp Ther 228:725–732

    Google Scholar 

  • Gobbi M, Frittoli E, Mennini T (1990) The modulation of [3H]noradrenaline and [3H]serotonin release from rat brain synaptosomes is not mediated by the α2B-adrenoceptor subtype. Naunyn-Schmiedeberg's Arch Pharmacol 342:382–386

    Google Scholar 

  • Goldberg MR, Robertson D (1983) Yohimbine: A pharmacological probe for study of the alpha2-adrenoceptors. Pharm Rev 35:143–170

    Google Scholar 

  • Göthert M, Huth H (1980) Alpha-adrenoceptor-mediated modulation of 5-hydroxytryptamine release from rat brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 313:21–26

    Google Scholar 

  • Göthert M, Huth H, Schlicker E (1981) Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 317:199–203

    Google Scholar 

  • Göthert M, Schlicker E (1991) Regulation of serotonin release in the central nervous system by presynaptic heteroreceptors. In: Feigenbaum J, Hanani M (eds) Presynaptic regulation of neurotransmitter release: A handbook. Freund, Tel Aviv, pp 845–876

    Google Scholar 

  • Gravel P, de Montigny C (1987) Noradrenergic denervation prevents sensitization of rat forebrain neurons to serotonin by tricyclic anti-depressant treatment. Synapse 1:233–239

    Google Scholar 

  • Hamilton CA, Reid JL, Yakubu MA (1988) [3H]Yohimbine and [3H]idazoxan bind to different sites on rabbit forebrain and kidney membranes. Eur J Pharmacol 146:345–348

    Google Scholar 

  • Hoyer D (1991) The 5-HT receptor family: Ligands, distribution and receptor-effector coupling. In: Rodgers RJ, Cooper SJ (eds) 5-HTIA agonists, 5-HT3 antagonists and benzodiazepines: Their comparative behavioral pharmacology. Wiley, Chichester, pp 31–57

    Google Scholar 

  • Kandel ER, Spencer WA (1961) Electrophysiology of hippocampal neurons. II. Afterpotentials and repetitive firing. Psychopharmacology 83:20–27

    Google Scholar 

  • Limberger N, Bonanno G, Späth L, Starke K (1986) Autoreceptors and α2-adrenoceptors at the serotonergic axons of rabbit brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 332:324–331

    Google Scholar 

  • Limberger N, Fischer MRG, Wichmann T, Starke K (1989) Phentolamine blocks presynaptic serotonin autoreceptors in rabbit and rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 340:52–61

    Google Scholar 

  • Limberger N, Starke K (1983) Partial agonist effect of 2-[2-(1,4-benzodioxanyl)]-2-imidazoline (RX 781094) at presynaptic α2-adrenoceptors in rabbit ear artery. Naunyn-Schmiedeberg's Arch Pharmacol 324:75–78

    Google Scholar 

  • Maura G, Gemignani A, Raiteri M (1985) α2-Adrenoceptors in rat hypothalamus and cerebral cortex: Functional evidence for pharmacologically distinct subpopulations. Eur J Pharmacol 116:335–339

    Google Scholar 

  • Maura G, Bonanno G, Raiteri M (1992) Presynaptic α2-adrenoceptors mediating inhibition of noradrenaline and 5-hydroxytryptamine release in rat cerebral cortex: Further characterization as different α2-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 345:410–416

    Google Scholar 

  • Michel MC, Regan JW, Gerhardt MA, Neubig RR, Insel PA, Motulsky HJ (1990) Noradrenergic [3H]idazoxan binding sites are physically distinct from alpha2-adrenergic receptors. Mol Pharmacol 37:65–68

    Google Scholar 

  • Mongeau R, Blier P, de Montigny C (1992) Electrophysiological evidence f for the desensitization of α2-adrenergic heteroreceptors on serotonin terminals in the rat hippocampus following chronic antidepressant treatments. Soc Neurosci Abstr 18:95.1

    Google Scholar 

  • Preziosi P, Martire M, Navarra P, Pistritto G, Vacca M (1989) Prolactin-lowering ability of (±)-idazoxan may be linked to a central noradrenergic-serotonergic interplay. J Pharmacol Exp Ther 249:256–263

    Google Scholar 

  • Raiteri M, Maura G, Folghera S, Cavazzani P, Andrioli GC, Schlicker E, Schalnus R, Göthert M (1990) Modulation of 5-hydroxytryptamine release by presynaptic inhibitory alpha-2-adrenoceptors in the human cerebral cortex. Naunyn-Schmiedeberg's Arch Pharmacol 342:508–512

    Google Scholar 

  • Raiteri M, Maura G, Versace P (1983) Functional evidence for two stereochemically different alpha-2 adrenoceptors regulating central noradrenaline and serotonin release. J Pharmacol Exp Ther 224:679–684

    Google Scholar 

  • Ross SB, Renyi AL (1975) Tricyclic antidepressant agents. II. Effects of oral administration on the uptake of 3H-noradrenaline and 14C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat. Acta Pharmacol Toxicol 36:395–408

    Google Scholar 

  • Schlicker E, Göthert M, Clausing R (1982) Acute or chronic changes of noradrenergic neurotransmission do not affect the α-adrenoceptor-mediated inhibition of 3H-serotonin release in the cerebral cortex. Naunyn-Schmiedeberg's Arch Pharmacol 320:38–44

    Google Scholar 

  • Schlicker E, Göthert M, Köstermann F, Clausing R (1983) Effects of α-adrenoceptor antagonists on the release of serotonin and noradrenaline from rat brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 323:106–113

    Google Scholar 

  • Tao R, Hjorth S (1992) α2-Adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 345:137–143

    Google Scholar 

  • Tibiriça E, Feldman J, Mermet C, Gonon F, Bousquet P (1991) An imidazoline-specific mechanism for the hypotensive effect of clonidine: A study with yohimbine and idazoxan. J Pharm Exp Ther 256:606–613

    Google Scholar 

  • Washburn M, Moises HC (1989) Electrophysiological correlates of presynaptic α2-receptor-mediated inhibition of norepinephrine release at locus-coeruleus synapses in dentate gyrus. J Neurosci 9:2131–2140

    Google Scholar 

  • Yoshioka M, Matsumoto M, Togashi H, Smith CB, Saito H (1992) Effect of clonidine on the release of serotonin from the rat hippocampus as measured by microdialysis. Neurosci Lett 139:57–60

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to R. Mongeau at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mongeau, R., Blier, P. & de Montigny, C. In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of α2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 347, 266–272 (1993). https://doi.org/10.1007/BF00167444

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00167444

Key words

Navigation